We use cookies for a better user experience. Read our Privacy Policy

I Agree

Metabolomics Market

Metabolomics Market (Gas Chromatography, Capillary Electrophoresis, High Performance Liquid Chromatography, Ultra Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry, Drug Assessment, Biomarker Discovery, Nutrigenomics, Clinical Toxicology) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Global Metabolomics Market: Overview

In recent years, there is immense use of metabolomics in the identification and quantification of cellular metabolites. This factor is projected to stimulate the growth of the global metabolomics market during the forecast period of 2016 to 2024. Metabolomics can be defined as a study of chemical processes that involve metabolites. One of the key purposes of metabolomics is to gain direct functional data of the physiological state of an organism.

In recent years, all major sectors are witnessing advancement in technology. Similarly, molecular biology is one of the key fields that have experienced immense technological development in recent times. This factor, in turn, is driving the development of metabolomics field. At the same time, the developments in analytical equipment and software are driving the growth of metabolomics field. Several vendors in the global metabolomics market are increasing investment in research and development activities. Moreover, governments of numerous countries are taking initiatives to support these research activities. Thus, growing support from government bodies from all across the world is fueling the growth of the global metabolomics market.

The report performs the segmentation of the market for metabolomics on the basis of application, technique, and regions.

Development in Pharmaceutical Sector Fuels Market Growth

The global metabolomics market is projected to experience remarkable growth avenues in the upcoming period. This dynamic growth can be attributed to development in the drug discovery segment and other related sectors in the pharmaceutical industry. In recent years, pharmaceuticals, life sciences, and chemicals fields are witnessing tremendous development. Owing to these developments, one of the key sectors that experienced remarkable advantages is the healthcare sector. Customized medicines and personalized therapeutics are some of the examples of this advancement. All these events have also worked as a driving factor for the global metabolomics market.

Growing number of worldwide older population is stimulating the growth of the global metabolomics market. Besides, increased incidences of chronic diseases including diabetes, cancer, and others will push the market growth in the upcoming period. Based on technique, the global metabolomics market is divided into two parts, namely, detection techniques and separation technique. Of them, detection techniques is further segmented into mass spectrometry (MS) and nuclear magnetic resonance spectroscopy (NMR)‏. Similarly, separation technique in the metabolomics market is bifurcated into capillary electrophoresis (CE)‏, gas chromatography (GC), ultra performance liquid chromatography (UPLC)‏, and high performance liquid chromatography (HPLC)‏.

Biomarker discovery, drug assessment, clinical toxicology, and nutrigenomics are some of the key applications owing to which the global metabolomics market is projected to witness stupendous growth avenues during years ahead. Other applications of metabolomics include gas chromatography, capillary electrophoresis, high performance liquid chromatography, ultra performance liquid chromatography, nuclear magnetic resonance spectroscopy, and mass spectrometry.

Unawareness about Benefits among End-users Makes Market Growth Sluggish

Some factors are projected to slow down the growth of the global metabolomics market during forecast period of 2016 to 2024. Majority of end-user industries are unaware about the advantages of metabolomics. Owing to this unawareness, there is mixed approach among a wide range of population toward the use of these technologies. This aside, the metabolomics market is witnessing lack of skilled professionals to work in this field. These are some of the most important factors hindering the growth of the global metabolomics market.

Strategic Moves by Key Enterprises Support in Driving Market Revenues

The global metabolomics market is fragmented in nature. It includes many small, medium, and large-scale players. As a result, the competitive landscape of the market for metabolomics highly intense. Well-established vendors in the market are chasing various strategic moves such as mergers and acquisitions. These moves are helping enterprises to gain and maintain leading position in the global metabolomics market.

Many vendors in the global metabolomics market are growing efforts to strengthen their production capabilities. To achieve this purpose, several enterprises have launched new production units. Numerous players are investing in marketing of their products. All these activities are opening remarkable opportunities for the growth of the global metabolomics market.

North America Offers Stupendous Avenues for Market Growth

The global metabolomics market is spread across five key regions, namely, Europe, Asia Pacific, North America, Middle East and Africa, and Latin America. Of them, North America is one of the leading regions in this market. Presence of significant number of key players is one of the key reasons driving the market growth in this region. Besides, increased technological development and high product commercialization are some of the vital factors stimulating the growth of the metabolomics market.

Asia Pacific is estimated to show promising opportunities for the growth of metabolomics market in the upcoming period. In recent years, the region is witnessing increased number of older population. As a result, there is increased demand for superior quality pharmaceutical products in emerging economics such as India and China. This is working as a driving factor for the metabolomics market. Besides, presence of key players and support from the government bodies will further boost the market growth in Asia Pacific.

The list of key players in metabolomics market includes Agilent Technologies, Inc.(U.S.), Thermo Fisher Scientific, Inc. (U.S.), Shimadzu Corporation (Japan), Biocrates Life Sciences AG (Austria), Human Metabolome Technologies, Inc.(Japan), Waters Corporation (U.S.), Metabolon, Inc. (U.S.), LECO Corporation (U.S.), Bruker Corporation (U.S.), and Bio-Rad Laboratories, Inc.(U.S.).

Metabolomics Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Table of Contents

Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation

Chapter 2 Executive Summary
2.1 Global Metabolomics Market Share, by Geography, 2015 Vs. 2024
2.2 Global Metabolomics Market, by Technique, 2015 (US$ Mn)
2.3 Global Metabolomics Market: Market Snapshot

Chapter 3 Global Metabolomics Market: Market Overview 
3.1 Introduction
3.2 Market Dynamics
     3.2.1 Drivers
     3.2.2 Restraints
     3.2.3 Opportunities
3.3 Porter's Five Forces Analysis
3.4 Market Attractiveness Analysis: Global Metabolomics market, by Geography , 2015, Value (%)
3.5 Competitive Landscape: Global Metabolomics Market, by Key, Players, 2015 (%)

Chapter 4 Global Metabolomics Market Revenue, By Technique, 2014-2024 (US $ Mn)
4.1 Introduction
4.2 Separation Techniques
     4.2.1 Gas Chromatography (GC)
     4.2.2 Capillary Electrophoresis (CE)‏
     4.2.3 High Performance Liquid Chromatography (HPLC)‏
     4.2.4 Ultra Performance Liquid Chromatography (UPLC)‏
4.3 Detection Techniques
     4.3.1 Nuclear Magnetic Resonance Spectroscopy (NMR)‏
     4.3.2 Mass Spectrometry (MS)

Chapter 5 Global Metabolomics Market Revenue, By Technique, 2014-2024 (US $ Mn)
5.1 Introduction
5.2 Drug Assessment
5.3 Biomarker Discovery
5.4 Nutrigenomics
5.5 Clinical Toxicology
5.6 Others

Chapter 6 Global Metabolomics Market Revenue, by Geography, 2013 - 2023 (USD Million)
6.1 Introduction
6.2 North America
     6.2.1 United States
     6.2.2 Canada
6.3 Europe
     6.3.1 Germany
     6.3.2 France
     6.3.3 Rest of Europe
6.4 Asia Pacific
     6.4.1 China
     6.4.2 Japan
     6.4.3 Rest of Asia Pacific
6.5 Latin America
     6.5.1 Brazil
     6.5.2 Rest of Latin America
6.6 Middle East and Africa (MEA)
     6.6.1 South Africa
     6.6.2 Rest of MEA 

Chapter 7 Company Profiles
7.1 Thermo Fisher Scientific Inc.
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Product Pipeline
7.1.4 Business Strategies
7.1.5 Recent Developments
7.2 Agilent Technologies, Inc.
7.3 Biocrates Life Sciences AG
7.4 Shimadzu Corporation
7.5 Waters Corporation
7.6 Human Metabolome Technologies Inc.
7.7 LECO Corporation
7.8 Metabolon Inc.
7.9 Bio-Rad Laboratories, Inc.
7.10 Bruker Corporation

List of Tables

Table. 1 Global Metabolomics Market: Market Snapshot
Table 2 Global Metabolomics Market Revenue, 2014 – 2024, (US$ Mn)
Table 3 Global Separation Techniques Market Revenue, 2014 – 2024, (US$ Mn)
Table 4 Global Detection Techniques Market Revenue, 2014 – 2024, (US$ Mn)
Table 5 Global Metabolomics Market Revenue, By Applications, 2014 – 2024, (US$ Mn)
Table 6 Global Metabolomics Market Revenue, by Geography, 2014 – 2024
Table 7 North America Metabolomics Market Revenue, by Country, 2014 – 2024
Table 8 Europe Metabolomics Market Revenue, by Country, 2014 – 2024
Table 9 Asia Pacific Metabolomics Market Revenue, by Country, 2014 – 2024
Table 10 Latin America Metabolomics Market Revenue, by Country, 2014 – 2024
Table 11 Middle East & Africa Metabolomics Market Revenue, by Country, 2014 – 2024

List of Figures

Fig.1 Market Segmentation
Fig 2 Global Metabolomics Market Share, by Geography, 2015
Fig.3 Global Metabolomics Market Share, by Geography, 2024
Fig. 4 Global Metabolomics Market, by Technique, 2015 (US$ Mn)
Fig. 5 Porter’s Five Forces Analysis
Fig. 6 Market Attractiveness Analysis: Global Metabolomics market, by Geography, 2015, Value (%)
Fig. 7 Competitive Landscape: Global Metabolomics Market, by Key, Players, 2015 (%)
Fig. 8 Gas Chromatography Market Revenue, 2014 – 2024, (US$ Mn)
Fig. 9 Capillary Electrophoresis Market Revenue, 2014 – 2024, (US$ Mn)
Fig. 10 High Performance Liquid Chromatography Market Revenue, 2014 – 2024, (US$ Mn)
Fig. 11 Ultra Performance Liquid Chromatography Market Revenue, 2014 – 2024, (US$ Mn)
Fig. 12 Mass Spectrometry (MS) Market Revenue, 2014 – 2024, (US$ Mn)
Fig. 13 Nuclear Magnetic Resonance (NMR) Market Revenue, 2014 – 2024, (US$ Mn
Fig. 14 Global Drug Assessment Market Revenue, 2014 – 2024, (US $ Mn)
Fig. 15 Global Biomarker Discovery Market Revenue, 2014 – 2024, (US $ Mn)
Fig. 16 Global Nutrigenomics Market Revenue, 2014 – 2024, (US $ Mn)
Fig. 17 Global Clinical Toxicology Market Revenue, 2014 – 2024, (US $ Mn)
Fig. 18 Thermo Fisher Scientific Inc.: Financial Overview: 2012–2014 (US$ Mn)
Fig. 19 Agilent Technologies, Inc.: Financial Overview: 2012–2014 (US$ Mn)
Fig. 20 Shimadzu Corporation: Financial Overview: 2013–2015 (US$ Mn)
Fig. 21 Waters Corporation: Financial Overview: 2012–2014 (US$ Mn)
Fig. 22 Bio-Rad Laboratories, Inc.: Financial Overview: 2012–2014 (US$ Mn)
Fig. 23 Bruker Corporation: Financial Overview: 2012–2014 (US$ Mn)

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

196

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved